ECA
ZBH icon

Elevated Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Elevated Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362 Hold
4
– – ﹤0.01% 805
2025
Q4 		$360 Buy
+4
New +$379 ﹤0.01% 789

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elevated Capital Advisors's ZBH Position: Q1 2026 in Review

Elevated Capital Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 4 shares worth $362. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Elevated Capital Advisors first reported a position in ZBH in Q4 2025 and has held it in 2 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Elevated Capital Advisors held 4 shares of Zimmer Biomet worth $362 as of Q1 2026.
  • Elevated Capital Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q1 2026, its #805 holding.
  • Elevated Capital Advisors first reported a position in Zimmer Biomet in Q4 2025 and has held it in 2 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.